Yifeng Tian

1.1k total citations
37 papers, 775 citations indexed

About

Yifeng Tian is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Yifeng Tian has authored 37 papers receiving a total of 775 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 14 papers in Surgery and 12 papers in Molecular Biology. Recurrent topics in Yifeng Tian's work include Pancreatic and Hepatic Oncology Research (12 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers) and RNA modifications and cancer (7 papers). Yifeng Tian is often cited by papers focused on Pancreatic and Hepatic Oncology Research (12 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers) and RNA modifications and cancer (7 papers). Yifeng Tian collaborates with scholars based in China. Yifeng Tian's co-authors include Shi Chen, Long Huang, Funan Qiu, Cheng‐Yu Liao, Jiang-Zhi Chen, Mao-Lin Yan, Baiyong Shen, Zuwei Wang, Jiaqiang Zhang and Yi Huang and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and Cell Reports.

In The Last Decade

Yifeng Tian

35 papers receiving 773 citations

Peers

Countries citing papers authored by Yifeng Tian

Since Specialization

Citations

This map shows the geographic impact of Yifeng Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yifeng Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yifeng Tian more than expected).

Fields of papers citing papers by Yifeng Tian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yifeng Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yifeng Tian. The network helps show where Yifeng Tian may publish in the future.

Co-authorship network of co-authors of Yifeng Tian

This figure shows the co-authorship network connecting the top 25 collaborators of Yifeng Tian. A scholar is included among the top collaborators of Yifeng Tian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yifeng Tian. Yifeng Tian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	SenExo‐cCCT2 Reprograms Senescence Response and Anti‐Tumor Immunity Following FOLFIRINOX Chemotherapy in Pancreatic Ductal Adenocarcinoma 2025 ·Advanced Science ·(unknown), (unknown), (unknown), (unknown), Yu Pan, Ge Li, Yongding Wu, Haoxiang Zhang, Xiaoxiao Huang, Yi‐Ting Chen, (unknown), Long Jin, Min Huang, Cheng‐Yu Liao, Long Huang, Yifeng Tian, Zuwei Wang, Qiaowei Li, Shi Chen	1
2	Machine learning-based prognostic prediction and surgical guidance for intrahepatic cholangiocarcinoma 2024 ·BioScience Trends ·(unknown), (unknown), (unknown), Liang Wang, Ge Li, (unknown), Chun Zhang, (unknown), Yifeng Tian, Shi Chen	2
3	Targeting the MCP‐GPX4/HMGB1 Axis for Effectively Triggering Immunogenic Ferroptosis in Pancreatic Ductal Adenocarcinoma 2024 ·Advanced Science ·(unknown), Cheng‐Yu Liao, (unknown), Zuwei Wang, (unknown), (unknown), Qiaowei Li, (unknown), (unknown), (unknown), Jianbo Li, Yi Huang, Yifeng Tian, Yanling Chen, Shi Chen	35
4	Escherichia coli‐Induced cGLIS3‐Mediated Stress Granules Activate the NF‐κB Pathway to Promote Intrahepatic Cholangiocarcinoma Progression 2024 ·Advanced Science ·(unknown), (unknown), Cheng‐Yu Liao, Yongding Wu, Ge Li, (unknown), (unknown), Long Huang, Yifeng Tian, Zuwei Wang, Shi Chen	14
5	A Novel Trojan Horse Nanotherapy Strategy Targeting the cPKM‐STMN1/TGFB1 Axis for Effective Treatment of Intrahepatic Cholangiocarcinoma 2023 ·Advanced Science ·(unknown), (unknown), (unknown), Cheng‐Yu Liao, Ge Li, Yongding Wu, (unknown), (unknown), Jianfei Hu, (unknown), Yi Huang, Yifeng Tian, Long Huang, (unknown), Shi Chen	20
6	Two machine learning-based nomogram to predict risk and prognostic factors for liver metastasis from pancreatic neuroendocrine tumors: a multicenter study 2023 ·BMC Cancer ·(unknown), Long Huang, Cheng‐Yu Liao, Guozhong Liu, Yifeng Tian, Shi Chen	15
7	Analgesic efficacy of an opioid-free postoperative pain management strategy versus a conventional opioid-based strategy following open major hepatectomy: an open-label, randomised, controlled, non-inferiority trial 2023 ·EClinicalMedicine ·Danfeng Wang, Cheng‐Yu Liao, Yifeng Tian, Ting Zheng, (unknown), (unknown), (unknown), Jiawei Su, Shi Chen, Xiaochun Zheng	5
8	Circular RNA circ-MTHFD1L induces HR repair to promote gemcitabine resistance via the miR-615-3p/RPN6 axis in pancreatic ductal adenocarcinoma 2022 ·Journal of Experimental & Clinical Cancer Research ·(unknown), Jianfei Hu, Zuwei Wang, Cheng‐Yu Liao, (unknown), (unknown), Yi Huang, Long Huang, Yifeng Tian, Shi Chen	38
9	Textbook outcomes of hepatocellular carcinoma patients with sarcopenia: A multicenter analysis 2022 ·European Journal of Surgical Oncology ·(unknown), Cheng‐Yu Liao, Danfeng Wang, Long Huang, Ge Li, Jiang-Zhi Chen, Liang Wang, (unknown), (unknown), Songqiang Zhou, Funan Qiu, Zhi‐Bo Zhang, Yanling Chen, (unknown), Xiaochun Zheng, Yifeng Tian, Shi Chen	16
10	SRSF3-mediated regulation of N6-methyladenosine modification-related lncRNA ANRIL splicing promotes resistance of pancreatic cancer to gemcitabine 2022 ·Cell Reports ·Zuwei Wang, Jingjing Pan, (unknown), Hongfei Zhang, Long Huang, Yi Huang, Cheng‐Yu Liao, Can Yang, Zhiwen Chen, (unknown), Baiyong Shen, Yifeng Tian, Shi Chen	76
11	A Prognostic Scoring System for Predicting Overall Survival of Patients with the TNM 8th Edition Stage I and II Hepatocellular Carcinoma After Surgery: A Population-Based Study 2021 ·Cancer Management and Research ·Yannan Bai, (unknown), Jiayi Wu, Shi Chen, (unknown), Yu Zheng, Yifeng Tian, Mao-Lin Yan, (unknown)	3
12	Prognostic value and association of sarcopenic obesity and systemic inflammatory indexes in patients with hepatocellular carcinoma following hepatectomy and the establishment of novel predictive nomograms 2021 ·Journal of Gastrointestinal Oncology ·Cheng‐Yu Liao, Ge Li, Yannan Bai, Songqiang Zhou, Long Huang, Mao-Lin Yan, Funan Qiu, (unknown), (unknown), Yifeng Tian, Shi Chen	17
13	Immunohistochemical Signature Add Prognostic Value in Patients With Early and Intermediate Hepatocellular Carcinoma Underwent Curative Liver Resection 2021 ·Frontiers in Oncology ·Yannan Bai, (unknown), Xiaoping Chen, Jiayi Wu, (unknown), Funan Qiu, Songqiang Zhou, Zijing Zhu, Yifeng Tian, (unknown), Yinghong Yang, (unknown)	3
14	SHCBP1 interacting with EOGT enhances O-GlcNAcylation of NOTCH1 and promotes the development of pancreatic cancer 2021 ·Genomics ·Can Yang, Jianfei Hu, Qian Zhan, Zuwei Wang, Ge Li, Jingjing Pan, Long Huang, Cheng‐Yu Liao, Yi Huang, Yifeng Tian, Baiyong Shen, Jiang-Zhi Chen, Yaodong Wang, Shi Chen	32
15	CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer 2021 ·Journal of Hematology & Oncology ·Shi Chen, Can Yang, Zuwei Wang, (unknown), Jingjing Pan, Cheng‐Yu Liao, Hongfei Zhang, Jiang-Zhi Chen, Yi Huang, Long Huang, Qian Zhan, Yifeng Tian, Baiyong Shen, (unknown)	73
16	The effectiveness, risks and improvement of laparoscopic pancreaticoduodenectomy during the learning curve: a propensity score-matched analysis 2020 ·Gland Surgery ·Long Huang, Yifeng Tian, Jiayi Wu, Mao-Lin Yan, Funan Qiu, Songqiang Zhou, Yannan Bai, (unknown), Yaodong Wang, Shi Chen	9
17	Silencing of long noncoding RNA LINC00958 prevents tumor initiation of pancreatic cancer by acting as a sponge of microRNA-330-5p to down-regulate PAX8 2019 ·Cancer Letters ·Shi Chen, Jiang-Zhi Chen, Jiaqiang Zhang, Huixing Chen, Funan Qiu, Mao-Lin Yan, Yifeng Tian, Chenghong Peng, Baiyong Shen, Yanling Chen, (unknown)	80
18	RER1 enhances carcinogenesis and stemness of pancreatic cancer under hypoxic environment 2019 ·Journal of Experimental & Clinical Cancer Research ·Shi Chen, Jiaqiang Zhang, (unknown), Yaodong Wang, Songqiang Zhou, Long Huang, Yannan Bai, Chenghong Peng, Baiyong Shen, Huixing Chen, Yifeng Tian	31
19	The over expression of long non-coding RNA ANRIL promotes epithelial-mesenchymal transition by activating the ATM-E2F1 signaling pathway in pancreatic cancer: An in vivo and in vitro study 2017 ·International Journal of Biological Macromolecules ·Shi Chen, Jiaqiang Zhang, Jiang-Zhi Chen, Huixing Chen, Funan Qiu, Mao-Lin Yan, Yanling Chen, Chenghong Peng, Yifeng Tian, (unknown)	44
20	Stearoyl-CoA desaturase-1 mediated cell apoptosis in colorectal cancer by promoting ceramide synthesis 2016 ·Scientific Reports ·Ling Chen, Jie Ren, Longhe Yang, Yanting Li, Jin Fu, Yuhang Li, Yifeng Tian, Funan Qiu, Zuguo Liu, Yan Qiu	86

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact